2021

Neuroblastoma risk assessment and treatment stratification with hybrid capture-based panel sequencing.
Szymansky, A. ORCID: https://orcid.org/0000-0003-4797-4526, Kruetzfeldt, L.M. ORCID: https://orcid.org/0000-0003-3630-3727, Heukamp, L.C., Hertwig, F. ORCID: https://orcid.org/0000-0003-4784-6516, Theissen, J., Deubzer, H.E. ORCID: https://orcid.org/0000-0002-6115-4893, Willing, E.M., Menon, R., Fuchs, S. ORCID: https://orcid.org/0000-0001-9619-4329, Thole, T., Schulte, S., Schmelz, K., Künkele, A. ORCID: https://orcid.org/0000-0002-8406-5412, Lang, P., Fuchs, J., Eggert, A., Eckert, C., Fischer, M., Henssen, A.G. ORCID: https://orcid.org/0000-0003-1534-778X, Rodriguez-Fos, E. ORCID: https://orcid.org/0000-0002-2555-0178 and Schulte, J.H. ORCID: https://orcid.org/0000-0003-0671-1201
Journal of Personalized Medicine 11 (8): 691. August 2021